Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive decline
Jetske van der Schaar(Amsterdam Neuroscience), Eva C. A. Asscher(Amsterdam University Medical Centers), Mardou S. S. A. van Leeuwenstijn‐Koopman(Amsterdam Neuroscience), Elsmarieke van de Giessen(Amsterdam Neuroscience), Sietske A. M. Sikkes(Amsterdam Neuroscience), Argonde C. van Harten(Amsterdam Neuroscience), Wiesje M. van der Flier(Amsterdam Neuroscience), Annelien L. Bredenoord(Erasmus University Rotterdam), Leonie N. C. Visser(Utrecht University), Calvin Trieu(Amsterdam Neuroscience), Mariette A. van den Hoven(Amsterdam University Medical Centers), Heleen M.A. Hendriksen(MACOM (United States))
Cited by 0
Related Papers
Addressing the risk of maladaptation to climate change
|Wiley Interdisciplinary Reviews Climate Change|2016|430
Gut Microbiota Composition Is Related to AD Pathology
|Frontiers in Immunology|2022|222
Herpes zoster after COVID vaccination
|International Journal of Infectious Diseases|2021|95
Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review
|Alzheimer s Research & Therapy|2022|66
Dementia risk communication. A user manual for Brain Health Services—part 3 of 6
|Alzheimer s Research & Therapy|2021|61